Afexa, Valeant Pharmaceuticals deal

Valeant completed its tender offer for Afexa, and now holds 89.5 million shares, or 81.6% of Afexa's outstanding shares. Valeant said it would acquire the remaining Afexa shares in a subsequent acquisition transaction. ...